Don’t Give Symptom-Free People Alzheimer’s Drugs
Mad in America
NOVEMBER 21, 2023
From The Hastings Center : “A large government-funded study of solanezumab , an experimental Alzheimer’s drug that targets amyloid in the brain, has found no benefit in people with normal cognitive function who have elevated amyloid levels.
Let's personalize your content